Lisa Chen, MD

The focus of my TB work has been as a clinician, education/training specialist, and global consultant for the programmatic management of drug-resistant TB. I am the principal investigator and medical director of the CDC-funded TB Center of Excellence, the Curry International Tuberculosis Center (CITC). The mission of CITC is to create, enhance and disseminate state-of-the-art resources and models of excellence and perform research to control and eliminate TB in the United States and internationally.  Committed to the belief that everyone deserves the highest quality of care in a manner consistent with his or her culture, values and language, CITC develops and delivers highly versatile, culturally appropriate trainings and educational products, and provides medical consultation and technical assistance. I am a co-editor of the CITC Drug-Resistant Tuberculosis: A Survival Guide for Clinicians, and have contributed to the development of the national drug-resistant TB guidelines for the U.S., as well as national guidelines, tools, policy, and programmatic quality improvement initiatives for the high-burden countries of Tanzania, Uganda and Indonesia. I am currently the Senior Director for Global Health, MECOR (Methods in Epidemiological, Clinical and Operations Research) program for the American Thoracic Society. MECOR is a multi-level research methods training course working to build research capacity in low- to middle-income countries through local partnerships in Latin America, Africa, China, Indonesia, Vietnam and Turkey. I also support TB advocacy work as a member of the Coordinating Board for STOP-TB USA since 2015.

UCSF Center for Tuberculosis Leadership & Initiatives:
SMART4TB Lead, Capacity Strengthening
World TB Day Oversight Planning Committee Member